Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

3,256 evidence items · page 110 / 131

2.2 %2.2% of the 92 presumptive pulmonary tuberculosis patients were pre-XDR/XDR-TB in Brazzaville, Republic of the Congo.

Gabonpre-XDR/XDR-TBobserved 2018 to 2019published 2021Annals of clinical microbiology and antimicrobialseurope_pmcdocument of 3 observationsDOI 10.1186/s12941-021-00488-x

150 ×10³/µLIn Gabonese patients, platelet counts were significantly lower in uncomplicated malaria compared to asymptomatic parasitemia (150 ×10³/µL).

Gabonpaludismepublished 2025Open forum infectious diseaseseurope_pmcdocument of 6 observations

39.3 %Single infections of gastrointestinal parasites occurred in 39.3% (115 out of 293) of infected chickens in the M'passa department, southeast Gabon.

Gabongastrointestinal parasitesobserved April and October 2022published 2024Open veterinary journaleurope_pmcdocument of 10 observations

46.8 %46.8% of the participants infected with both Ascaris lumbricoides and Trichuris trichiura had malaria parasites.

Gabonpaludismeobserved October 2020 to January 2021published 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 10 observations

49 ansL’âge moyen des 178 patientes atteintes de cancer du sein suivies à l'Institut de cancérologie d'Akanda était de 49 ± 11 ans entre juin et octobre 2022.

Gaboncancer du seinobserved Juin 2022 à octobre 2022HAL · Unilimdocument of 322 observations

0.11 per_person_yearThe incidence of haematuria was 0.11 person-years.

Gabonhaematuriapublished 2019Parasites & vectorseurope_pmcdocument of 20 observations

35,055 p/μLParasite density was 35,055 parasites per microliter in 2011.

Gabonpaludismeobserved 2011published 2011Sante (Montrouge, France)europe_pmcdocument of 8 observations

35.6 %L. loa microfilaremia was found in 353 out of 981 (35.6%) participants.

GabonL. loa microfilaremiaHAL · Unilimdocument of 153 observations

100 per_1The ratio of seroprevalence from infection to cumulative incidence of confirmed cases was 100:1 overall in Africa.

GabonCOVID-19published 2022BMJ global healtheurope_pmcdocument of 4 observationsDOI 10.1136/bmjgh-2022-008793

38.5 %The proportion of patients with clinical malaria requiring parenteral treatment was 38.5%.

Gabonpaludismepublished 2014BioMed research internationaleurope_pmcdocument of 6 observationsDOI 10.1155/2014/351281

250,000,000 peopleSchistosomiasis affects more than 250 million people globally.

Gabonschistosomiasepublished 2024Frontiers in parasitologyeurope_pmc

50.9 %L’Aspiration Manuelle Intra-Utérine (AMIU) a été pratiquée dans 50,9 % des cas de prise en charge d’avortement clandestin au Centre Hospitalier Universitaire de Libreville entre 2014 et 2018.

Gabonavortement clandestinobserved 2014 à 2018published 2021Revue de médecine et de pharmacieOpenAlexdocument of 24 observations

9 casesNine Gabonese cases of systemic lupus associated with HIV were reported.

Gabonsystemic lupus · VIH/sidaobserved 2016-04-30 to 2024-04-30published 2024Medecine tropicale et sante internationalePubMeddocument of 8 observations

1 caseOne fatal case of CPE-associated bacteremia was identified in one of the 203 newborns.

GabonCPE-associated bacteremiaobserved 2022published 2024Frontiers in cellular and infection microbiologyeurope_pmcdocument of 12 observationsDOI 10.3389/fcimb.2024.1341161

56.1 hoursMedian time to parasite clearance was 56.1 hours with ferroquine alone.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 13 observations

23.1 %High parasitemia occurred in 23.1% of HIV-negative patients with malaria.

Gabonpaludisme · VIH/sidaobserved 2021 to 2022published 2026PloS onePubMeddocument of 11 observations

4 %The proportion of Anopheles gambiae mosquitoes infected with Plasmodium malariae coinfections via direct membrane feeding assay without serum replacement was 4% (2 of 45).

Gabonpaludismepublished 2021The Journal of infectious diseaseseurope_pmcdocument of 4 observationsDOI 10.1093/infdis/jiaa382

91.42 %The seroprevalence of SARS-CoV-2 antibodies in the 40–49 age group in Gabon was 91.42% (95% CI: 88.7–93.5).

GabonCOVID-19observed up to December 2021published 2024SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from the Nationwide Household Serosueurope_pmcdocument of 6 observations

69 %Eleven of the cases (69%) were the result of reinfection.

Gabonparasitemiapublished 2005The Journal of infectious diseaseseurope_pmcdocument of 6 observations

0 casesAmong participants, there were no cases of hookworm infection.

GabonankylostomiaseHAL · Unilimdocument of 153 observations

Helminth mono-infection, particularly Schistosoma haematobium and soil-transmitted helminths, was significantly associated with earlier malaria episodes following controlled human malaria infection.

Gabonpaludisme · schistosomiase · soil-transmitted helminthspublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 4 observationsDOI 10.1371/journal.pntd.0009361

65 %The allergens most commonly causing sensitization were from mites, with a positivity rate of 65%.

Gabonallergyobserved 2018 to 2021published 2022Journal of Allergy and Clinical Immunology GlobalOpenAlexdocument of 5 observations

10.6 %10.6% of non-carriers had hospitalization in the past 15 days.

Gabonhospitalization in the past 15 daysobserved 2022published 2024Frontiers in cellular and infection microbiologyeurope_pmcdocument of 12 observationsDOI 10.3389/fcimb.2024.1341161

0 %The YYD haplotype prevalence was 0.0% in symptomatic infections and 7.1% in asymptomatic infections.

Gabonpaludismepublished 2021Infection and drug resistanceeurope_pmcdocument of 10 observationsDOI 10.2147/idr.s304361

26.2 %Impaired consciousness occurred in 26.2% of PLHIV with malaria.

Gabonpaludisme · VIH/sidaobserved 2021 to 2022published 2026PloS onePubMeddocument of 11 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.